Antigenics, Inc. (AGEN)
A biotechnology company, developing technologies and products to treat cancers and infectious diseases, based on immunological approaches.
Recs
beachjim37
(< 20)
Submitted: 10/12/2009 6:46:36 AM :
Start Price:
$2.11
AGEN Score:
-65.66
Great news in next 90 days likely
Recs
flatky02
(< 20)
Submitted: 10/5/2009 6:50:10 AM :
Start Price:
$2.04
AGEN Score:
-69.50
This BioPharm is getting hot. I'd say that this company and CVM are nippin at the heals of large sector growth. We should see a double in stock price within a year... but probably more. Give it a few years... and this is a potential billion dollar company in the $20 stock range. Great price to buy!
Recs
ikghassassin
(< 20)
Submitted: 10/3/2009 4:28:36 PM :
Start Price:
$2.04
AGEN Score:
-69.23
Way oversold, good fundamentals, long term hold
Recs
ajnapower
(< 20)
Submitted: 10/2/2009 11:50:32 AM :
Start Price:
$2.02
AGEN Score:
-69.26
Se il famaco funziona in Russia ci saranno ottime aspettative per la commercializzazione in Europa e negli usa
Recs
libertybrewcity
(< 20)
Submitted: 9/10/2009 10:24:31 PM :
Start Price:
$2.43
AGEN Score:
-73.59
seems like a decent stock. only about a million in sales per quarter and a fairly substantial amount of long term debt, but there is promise for both drugs in phase 2.
Recs
Brian7992
(< 20)
Submitted: 8/11/2009 2:29:09 PM :
Start Price:
$2.07
AGEN Score:
-73.45
How Should I know!
Recs
number90
(< 20)
Submitted: 8/4/2009 10:19:21 PM :
Start Price:
$2.32
AGEN Score:
-76.50
Time to buy.... stock has finished consolidating... recent upward change to private placement price, plus recent move in stock price confirms big money wants in... should see a nice run as summer ends and we get closer to EMEA decision
Recs
SaratogaPhil
(< 20)
Submitted: 8/4/2009 5:45:10 AM :
Start Price:
$2.55
AGEN Score:
-80.31
Oncophage vaccine is targeted at kidney cancer, metastatic melanoma and brain tumors. Works well on stage-one and -two cancers. Testing 20 vaccines, including with GSK.
Recs
exodus69
(78.04)
Submitted: 8/2/2009 8:38:03 PM :
Start Price:
$2.65
AGEN Score:
-81.55
I can smell another DNDN or HGSI coming. Just be patient with this one. Can be volatile short-term, but potentially a multi-bagger once they report positive results for their late-stage Oncophage vaccine which targets at kidney cancer, metastatic melanoma and brain tumors . On top of that Antigenics has QS-21 Stimulon adjuvant that improves the efficacy of vaccines. Great pipeline and potential here. Don't miss out.
Recs
poconobear
(98.00)
Submitted: 7/25/2009 7:48:51 AM :
Start Price:
$2.30
AGEN Score:
-79.43
biotech spec
Recs
svande8952
(22.98)
Submitted: 6/16/2009 11:09:34 AM :
Start Price:
$2.04
AGEN Score:
+82.21
recent run up looks prime for thumbs down
Recs
TMFBiologyFool
(90.99)
Submitted: 6/12/2009 12:29:55 PM :
Start Price:
$2.03
AGEN Score:
+79.88
You need phase 3 data to get an approval (in this country). :)
Recs
Anachronism
(89.91)
Submitted: 9/17/2008 3:41:07 PM :
Start Price:
$1.59
AGEN Score:
-48.61
I expect to see companies like this come up with the next administration with all the pressure to fix health-care.
Recs
sbream
(< 20)
Submitted: 7/1/2008 9:23:03 PM :
Start Price:
$1.90
AGEN Score:
-47.69
Hopefully FDA approves the export...
Recs
Recs
4reverse4
(< 20)
Submitted: 5/12/2008 1:25:22 AM :
Start Price:
$2.31
AGEN Score:
-48.70
Chart is looking up! Buying and then selling in a couple weeks when I feel it's peaked
Recs
nolaig90
(< 20)
Submitted: 5/9/2008 7:10:48 AM :
Start Price:
$2.33
AGEN Score:
-49.48
once sales of this product hit the market and there proven benifits to the vacine i can see this stock grow expotentially.
Recs
Marauder03
(< 20)
Submitted: 4/25/2008 11:51:52 AM :
Start Price:
$2.23
AGEN Score:
-47.93
Who wouldn't want a vaccine to save their life?
Recs
antigrowth
(< 20)
Submitted: 4/10/2008 2:17:16 AM :
Start Price:
$2.77
AGEN Score:
-56.49
Will pop up because of the russian approval.
Recs
cooker0stp
(< 20)
Submitted: 4/9/2008 8:53:20 PM :
Start Price:
$2.77
AGEN Score:
-56.49
Russia will become haven for terminal cancer patients.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 35 1 2 Next »